Genzyme opens new research center in Framingham

FRAMINGHAM, Mass. (AP) -- Genzyme Corp. has opened a new 180,000-square foot science center in Framingham where researchers will work on discovering new treatments for a range of ailments including Parkinson's disease, cancer and heart disease.

The Cambridge-based biotechnology company opened the facility Monday. It is expected to employ up to 350 people.

Researchers at the center will focus on medical areas including genetic, immune, kidney and cardiovascular diseases, endocrinology and neurological disorders.

The facility meets federal "green building" standards and uses an estimated 26 percent less energy and 40 percent less water than a comparable conventional building.

(Copyright 2008 by The Associated Press. All Rights Reserved.)

Join the Conversation!

To comment, the following rules must be followed:

  • No Obscenity, Profanity, Vulgarity, Racism or Violent Descriptions
  • No Negative Community Comparisons
  • No Fighting, Name-calling, or Personal Attacks
  • Multiple Accounts are Not Allowed
  • Stay on Story Topic

Comments may be monitored for inappropriate content, but the station is under no legal obligation to do so.
If you believe a comment violates the above rules, please use the Flagging Tool to alert a Moderator.
Flagging does not guarantee removal.

Multiple violations may result in account suspension.
Decisions to suspend or unsuspend accounts are made by Station Moderators.
Links require admin approval before posting.
Questions may be sent to Please provide detailed information.

powered by Disqus


6450 Papermill Drive Knoxville, TN 37919 Phone - (865) 450-8888; Fax - (865) 450-8869
Copyright © 2014 WVLT-TV Inc. - Designed by Gray Digital Media - Powered by Clickability 29256704 -
Gray Television, Inc.